Detalles de la búsqueda
1.
Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemia.
Hematol Oncol
; 38(5): 754-762, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32950042
2.
The e13a2 BCR-ABL transcript negatively affects sustained deep molecular response and the achievement of treatment-free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors.
Cancer
; 125(10): 1674-1682, 2019 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30707758
3.
Molecular remission at the end of treatment is a necessary goal for a good outcome in ELN favorable-risk acute myeloid leukemia: a real-life analysis on 201 patients by the Rete Ematologica Lombarda network.
Ann Hematol
; 97(11): 2107-2115, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30009341
4.
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax.
Am J Hematol
; 98(4): E80-E83, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36651870
5.
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
N Engl J Med
; 369(2): 111-21, 2013 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-23841729
6.
Relapsing bloodstream infections during treatment of acute leukemia.
Ann Hematol
; 93(5): 785-90, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24288110
7.
Prognostic Relevance of NPM1 and FLT3 Mutations in Acute Myeloid Leukaemia, Longterm Follow-Up-A Single Center Experience.
Cancers (Basel)
; 14(19)2022 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36230640
8.
A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study).
J Antimicrob Chemother
; 66(9): 2140-5, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21729932
9.
Validation of the "fitness criteria" for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL).
J Geriatr Oncol
; 12(4): 550-556, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33097455
10.
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome.
Leuk Res
; 84: 106191, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31386932
11.
Invasive pulmonary aspergillosis in acute leukemia: a still frequent condition with a negative impact on the overall treatment outcome.
Leuk Lymphoma
; 60(12): 3044-3050, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31120311
12.
Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol.
Leuk Lymphoma
; 60(14): 3482-3492, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31298059
13.
Myeloid neoplasm occurrence during stable molecular remission of NPM1-mutated AML: are we facing secondary disease or AML relapse?
Blood Cancer J
; 13(1): 194, 2023 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38129393
14.
Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis.
Oncotarget
; 8(45): 79073-79086, 2017 Oct 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29108288
15.
Continuous oral cyclophosphamide and prednisolone as a valuable treatment option for peripheral T cell lymphoma.
Br J Haematol
; 152(1): 113-6, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20880109
16.
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients.
Cancer Med
; 5(2): 265-74, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26715369
17.
Lenalidomide in patients with red blood cell transfusion-dependent myelodysplastic syndrome and del(5q): a single-centre "real-world" experience.
Leuk Lymphoma
; 56(11): 3129-34, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25811676
18.
Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomes.
J Clin Oncol
; 32(30): 3406-12, 2014 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25245446
19.
Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes.
Leukemia
; 33(3): 785-790, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30291338
Resultados
1 -
19
de 19
1
Próxima >
>>